The A-Alpha Bio team. The Seattle startup generates protein interaction data and partners with drug ... A-Alpha Bio is among a growing flock of startups using AI as a tool to help scientists ...

May 06, 2025 (GLOBE NEWSWIRE) -- Upstream Bio ... Top-line data from this clinical trial is expected to be reported in the third quarter of 2025. The Company has designed this trial using ...

(“Zura Bio”), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced it will present data from its tibulizumab ...

Aug. 16, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the ... today announced the first data from the indolent lymphoma cohort of the Company’s ongoing multicenter Phase ...

Artificial intelligence (AI) will fundamentally change medicine and healthcare: Diagnostic patient data, e.g. from ECG ... now succeeded in developing a bio-compatible implantable AI platform ...

(RTTNews) - INmune Bio, Inc. (INMB), on Tuesday presented baseline ... Preliminary baseline data confirm that the trial has successfully enrolled a well-characterized Early AD patient cohort ...

M.D., President and Chief Executive Officer of Goldfinch Bio, commented, “We are pleased with the initial findings of clinical activity in our Phase 2 trial of GFB-887. These data provide ...

Here we apply it to biological data, using three well-characterized mass cytometry and single-cell RNA sequencing datasets. Comparing the performance of UMAP with five other tools, we find that ...